Are you a new member? Sign up now
Login area
| Sign up
close
JAKAVI - 15mg - 56
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EJ01 | B | Ruxolitinib - 15mg | 11838 | 34423/1 | JAKAVI | 15mg | 56 | Tablet | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 314,193,119 L.L | 2.44 | E2 | Novartis Europharm Limited | Ireland | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EJ01 | G | Ruxolitinib - 15mg | 11480 | 152420/1 | CELEZON | 15mg | 56 | Tablet | Oral | Droguerie de l'Union | The Arab Pharmaceutical Manufacturing PSC | Jordan | 188,515,591 L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
| L01EJ01 | G | Ruxolitinib - 15mg | 11480/388 | 152420/1 | CELEZON | 15mg | 56 | Tablet | Oral | Droguerie de l'Union | The Arab Pharmaceutical Manufacturing PSC | Jordan | L.L | 2.44 | E2 | Hikma Pharmaceuticals | Jordan | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024